MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor (MITF) mRNA is inhibited by...

Area of Science:

• Molecular Biology
• Cancer Biology
• Post-transcriptional Regulation

Background:

• Alternative cleavage and polyadenylation produces mRNA variants with distinct 3'-UTR lengths, enabling differential gene regulation.
• Microphthalmia-associated transcription factor (MITF) is crucial for melanocyte development and is implicated in melanoma.
• Post-transcriptional regulation plays a significant role in controlling gene expression, particularly in cancer.

Purpose of the Study:

• To investigate the regulation of MITF mRNA isoforms in melanoma.
• To identify the role of microRNA (miRNA) and RNA-binding proteins in controlling MITF expression.
• To elucidate the mechanism by which MITF is dysregulated in malignant melanoma.

Main Methods:

• Analysis of MITF mRNA 3'-UTR variants in melanoma cells.
• Investigation of miR-340 interaction with MITF 3'-UTR.
• Assessment of coding region determinant-binding protein (CRD-BP) binding to MITF mRNA.
• Evaluation of the impact of these interactions on MITF expression and activity.

Main Results:

• Melanoma cells preferentially express MITF mRNA with a shorter 3'-UTR.
• miR-340 directly binds to the MITF 3'-UTR, leading to mRNA degradation and reduced MITF activity.
• CRD-BP binds to the MITF 3'-UTR, inhibiting miR-340 binding and stabilizing MITF transcripts.
• This interplay results in elevated MITF expression and activity in melanoma.

Conclusions:

• Melanoma exhibits a regulatory mechanism involving alternative polyadenylation and specific RNA-binding proteins and miRNAs that impacts MITF levels.
• The balance between miR-340 and CRD-BP binding to the MITF 3'-UTR is critical for controlling MITF expression in both normal melanocytes and melanoma.
• Understanding this regulatory network provides insights into melanoma pathogenesis and potential therapeutic targets.